Condition
Subjective Cognitive Decline (SCD) clinical trials and research
As of November 12, 2026, Find a Trial lists 26 Subjective Cognitive Decline (SCD) clinical trials that are recruiting, at sites in 23 countries (most in United States (7), Italy (7), Taiwan (3)). 2 were first registered in the last 30 days. By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 26Clinical trials
- 2New in 30 days
- 23Countries
Newest Subjective Cognitive Decline (SCD) clinical trials
All recruiting trials (26)
-
Daily-life Virtual Reality Training to Support Thinking and Daily Tasks in adults 50 and older
A touchscreen-based daily-life VR program is being tested to see if it helps people 50+ improve daily activities and thinking skills, especially for those at risk of dementia.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
Longitudinal profiling of plasma-derived glial extracellular vesicles in Alzheimer's disease
This study tests whether plasma glial extracellular vesicles and neuroinflammation biomarkers change over time across the Alzheimer’s disease spectrum and whether these signals relate to amyloid, tau, and neurodegeneration, with an additional step of exposing healthy iPSC-derived neurons to vesicles to see potential ne
-
Digital tools to predict Alzheimer's biology from risk factors
This study tests a digital, AI-based tool that analyzes modifiable and non-modifiable risk factors to see if it can predict biological changes linked to Alzheimer's disease in adults with MCI or SCD.
-
Personalized Brain Health Service for Dementia Prevention in People with Subjective Cognitive Decline
This study tests a personalized Brain Health Service to see if tailored risk assessment and a 6‑month lifestyle program can lower dementia risk for people aged 55–85 who have subjective cognitive concerns.
-
Virtual reality-based cognitive and physical rehab for people with mild cognitive impairment or subjective cognitive decline
This study tests whether VR-based cognitive and physical rehabilitation is feasible, usable, and acceptable for people with mild cognitive impairment or subjective cognitive decline.
-
Chinese Classics recitation training for people with subjective memory concerns
A 6-month program of Chinese Classics recitation is being tested to see if it helps people aged 60+ who notice memory problems but don’t have measurable impairment.
-
Lombardy Brain Health Services cohort
This project will see if a blood biomarker (pTau-217), together with clinical and cognitive tests, can help distinguish adults in Lombardy who have subjective cognitive decline, functional cognitive disorder, or are worried about their thinking.
-
Finding signs of Alzheimer's in people with subjective memory complaints
The study will test whether inexpensive, easy-to-get measures—like blood markers, EEG and automated speech analysis—can help identify early Alzheimer's in people who notice memory or thinking changes but have normal standard tests.
-
See if three months of visual flicker at 16.67 Hz helps cognition and mood in older adults with or without subjective cognitive concerns
This study tests whether three months of flicker stimulation three times a week can improve thinking, movement, and mood in healthy older adults and those with subjective cognitive decline.
-
Spermidine to improve sleep and memory in mild cognitive impairment
This will see if taking daily spermidine supplements for 12 weeks improves sleep quality and sleep-related memory in older adults with MCI due to Alzheimer's disease.
-
Online positive psychology program to support thinking and brain health in early memory changes
This study will test whether an online positive psychology program can improve thinking, brain function, and wellbeing in older adults with early memory problems (Subjective Cognitive Decline or Mild Cognitive Impairment).
-
Personalized digital training for cognitive fitness in people with mild cognitive impairment
This study tests whether a personalized home-based digital program (RICORDO) helps people aged 50 and older with mild cognitive impairment or subjective cognitive decline manage their health and daily life better than a paper-and-video education program.
-
NPC-1 (parthenolide and ipriflavone) for Alzheimer's blood biomarkers
This trial will test whether taking NPC-1 (a combination of parthenolide and ipriflavone) is safe, well tolerated, and changes blood tests linked to Alzheimer's in adults 55+ with subjective cognitive decline, mild cognitive impairment, or mild Alzheimer's who have biomarker evidence of disease.
-
InRAD international registry for Alzheimer's disease and related dementias
This project will collect routine medical information over time to see how Alzheimer's disease, mild cognitive impairment, and related dementias progress and how current treatments are tolerated in adults.
-
Accelerated deep TMS to boost memory and thinking in older adults with mild memory problems
We will test whether a short, intensive course of deep transcranial magnetic stimulation to the anterior cingulate plus online cognitive training can improve memory and thinking in people aged 55–85 with mild cognitive impairment or subjective memory decline.
-
FACE Phase II: Facial-expression personalization for at-home cognitive training
This project tests whether a facial-expression personalization system can track and adjust real-time engagement to improve adherence to home-based computerized cognitive training for older adults at risk for Alzheimer's disease.
-
Boosting physical activity with tech, social support, and stress resilience
This study tests whether adding technology-based tools plus social support and stress-resilience activities helps older adults living alone with subjective cognitive decline become more physically active.
-
Korean Joint Registry for Alzheimer's Treatment and Diagnostics
This study is testing new Alzheimer's treatments, like lecanemab and donanemab, to see how well they work and are safe for people with Alzheimer's in South Korea.
-
Olfactory Network Testing with Electro-acupuncture for Subjective Cognitive Decline
This study tests whether electro-acupuncture can help people aged 55–79 with subjective cognitive decline, by looking at changes in their brain’s smell-related networks.
-
Validation of Italian cognitive assessment scales for elderly patients
This study is trying to see if new Italian versions of cognitive and daily living assessments can help doctors better diagnose neurodegenerative diseases in older Italian-speaking patients.
-
Improving sleep in older adults with mild cognitive impairment using brain stimulation and CBT-I
This trial will try combining gentle transcranial magnetic stimulation (TMS) with cognitive behavioral therapy for insomnia (CBT-I) to improve sleep in people aged 60 and older who have mild cognitive impairment or subjective cognitive decline.
-
Improving sleep quality to enhance memory in older adults with mild cognitive impairment
This study is testing whether using special sounds during sleep can help older adults with mild memory problems sleep better and improve their memory over time.
-
A program to engage people with memory challenges in outdoor activities
This study is testing a new outdoor activity program for people with memory challenges and their partners to see if it helps them feel better and enjoy nature more.
-
Investigating brain mechanisms for cognitive assessment and rehabilitation in cognitive decline
This study is testing different ways to improve thinking skills in people with mild cognitive decline by looking at brain activity and trying out activities like training, exercise, and games.
-
Comprehensive assessment of neurodegeneration and dementia
This project will collect brain scans, cognitive tests, and biological samples over time to see how dementia and related conditions progress in adults aged 50–90, including people with Parkinson's and people without cognitive problems.
Related topics
Quick answers
How many Subjective Cognitive Decline (SCD) clinical trials are recruiting right now?
26, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 23 countries. The most sites are in United States (7 trials), Italy (7 trials), Taiwan (3 trials), China (3 trials), Greece (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.